Optimal Antithrombotic Regimens for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: An Updated Network Meta-analysis

IMPORTANCE: Antithrombotic treatment in patients with atrial fibrillation (AF) and percutaneous coronary intervention (PCI) presents a balancing act with regard to bleeding and ischemic risks. OBJECTIVES: To evaluate the safety and efficacy of 4 antithrombotic regimens by conducting an up-to-date ne...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:JAMA Cardiol
Auteurs principaux: Lopes, Renato D., Hong, Hwanhee, Harskamp, Ralf E., Bhatt, Deepak L., Mehran, Roxana, Cannon, Christopher P., Granger, Christopher B., Verheugt, Freek W. A., Li, Jianghao, ten Berg, Jurriën M., Sarafoff, Nikolaus, Vranckx, Pascal, Goette, Andreas, Gibson, C. Michael, Alexander, John H.
Format: Artigo
Langue:Inglês
Publié: American Medical Association 2020
Sujets:
Brief Report
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7240352/
https://ncbi.nlm.nih.gov/pubmed/32101251
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamacardio.2019.6175
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires